Historic Federal Cannabis Rescheduling Poised to Boost Safe Harbor Financial's Client Base and Market
SHFS sits 25% above its 52-week low of $0.709 on elevated volume (4.3× avg).
Summary
SHF Holdings, operating as Safe Harbor Financial, announced that the Department of Justice's historic rescheduling of state-licensed medical cannabis from Schedule I to Schedule III is expected to significantly benefit its business. This regulatory change, effective April 22, 2026, removes the onerous 280E tax burden for qualifying medical cannabis operators, which previously faced effective federal tax rates of 70% or higher. For Safe Harbor Financial, this is anticipated to improve client financial health, leading to more stable deposits, reduced account churn, and better loan performance within its core banking business. Furthermore, the company expects an expanded total addressable market as the reduced federal risk profile may encourage more financial institutions to enter the cannabis banking space, potentially becoming customers for Safe Harbor's compliance platform. This positive industry development is particularly critical for SHFS, which recently disclosed substantial doubt about its ability to continue as a going concern and a Nasdaq delisting risk in its 2025 10-K filing. Investors should monitor how quickly these anticipated benefits translate into improved financial performance for SHFS and its ability to leverage the new market opportunities.
At the time of this announcement, SHFS was trading at $0.89 on NASDAQ in the Finance sector, with a market capitalization of approximately $3.9M. The 52-week trading range was $0.71 to $9.19. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.